Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts

Zhuo, JY; Lu, D; Wang, JG; Lian, ZX; Zhang, JL; Li, HH; Cen, BN; Wei, XY; Wei, Q; Xie, HY; Xu, X

Xu, X (corresponding author), Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Ctr Integrated Oncol & Precis Med, Dept Hepatobiliary & Pancreat Surg,Sch Med, Hangzhou 310003, Peoples R China.; Xu, X (corresponding author), Zhejiang Univ, Natl Hlth Commiss, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Peoples R China.; Xu, X (corresponding author), Zhejiang Univ, Inst Organ Transplantat, Hangzhou 310003, Peoples R China.

CHINESE JOURNAL OF CANCER RESEARCH, 2021; 33 (4): 470

Abstract

Objective: Patient-derived xenograft (PDX) models provide a promising preclinical platform for hepatocellular carcinoma (HCC). However, the molecular ......

Full Text Link